Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration
Conditions
Brief summary
The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration. Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.
Interventions
DEVICEActive microcurrent therapy
Non-invasive transpalpebral microcurrent therapy delivery to the upper and lower eyelids
Sponsors
Professor Timothy Jackson, King's College
i-Lumen Scientific, Inc.
Jarding, John, OD
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults aged at least 50 years with dry AMD in at least one eye
Exclusion criteria
* Eye diseases other than dry AMD * Implanted electrical devices * Seizure disorders
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean logMAR BCVA | Week 1 | Mean logarithm of the minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) following the last treatment |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of improved, stable or worsened BCVA | Week 1 | Proportion of eyes with improved, stable or worsened BCVA, and BCVA with both eyes open |
Outcome results
None listed